跳至主要内容
临床试验/NCT03642795
NCT03642795招募中不适用

Validation of the French Version of the CQR (Compliance Questionnaire Rheumatology): Specific Tool for Evaluation of Observance of Rheumatology Treatment

Centre Hospitalier Universitaire de Nīmes4 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2022年6月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
150
试验地点
4
主要终点
Test-retest agreement of French translation of the Compliance Questionnaire Rheumatology questionnaire

研究概览

简要总结

The purpose of this study is to develop a French language version of the Compliance-Questionnaire-Rheumatology for use in French and Francophone rheumatology services

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient is at least 18 years old
  • The patient has rheumatoid polyarthritis as defined by the ACR-EULAR 2010 criteria, treated orally or subcutaneously with MTX for at least 3 months with a stable (unchanged) dosage for at least 1 month, and a stable (unchanged) route of administration for at least 1 month. And no planned change in Methotrexate intake at least until the second study visit. Other treatments at the same time are authorized

排除标准

  • The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • The subject has a contraindication to taking methotrexate (including a patient with a desire to become pregnant).

结局指标

主要结局

Test-retest agreement of French translation of the Compliance Questionnaire Rheumatology questionnaire

时间窗: 40 minutes

Intraclass correlation and Kappa coefficient of 2 evaluations taken 40 minutes apart

Structural validity of French translation of the Compliance Questionnaire Rheumatology questionnaire

时间窗: Baseline

Principal component analysis

次要结局

  • Validation of the Compliance Questionnaire Rheumatology against gold standard (erythrocyte methotrexate polyglutamates (MTX PGs) concentration)(Baseline)
  • Rate of missing responses to each question of French translation of Compliance Questionnaire Rheumatology(Baseline)
  • Rate of questionnaires with at least 1 missing item(Baseline)
  • Validation of the short form of the French Compliance Questionnaire Rheumatology(Baseline)
  • Compare French Compliance Questionnaire Rheumatology results against general questionnaire Morisky Medication Adherence Scale (MMAS-8)(Baseline)
  • Sex of observant versus non-observant patients(Month 1)
  • Age of observant versus non-observant patients(Month 1)
  • education level of observant versus non-observant patients(Month 1)
  • profession of observant versus non-observant patients(Month 1)
  • marital status of observant versus non-observant patients(Month 1)
  • Number patients observing medication(Month 1)
  • Quality of life in observant versus non-observant patients(Month 1)
  • Health-related quality of life in observant versus non-observant patients(Month 1)
  • Functional incapacity in observant versus non-observant patients(Month 1)
  • Pain experience in observant versus non-observant patients(Month 1)
  • Cognitive representations of medication in observant versus non-observant patients(Month 1)

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Validation of the French Version of the CQR... | 临床试验